The reiteration of an Overweight rating by Morgan Stanley analyst Vincent Andrews indicates a positive outlook for Eastman Chemical's stock. The maintained $115 price target suggests that the analyst believes the stock has potential for growth in the short term. This news is likely to have a positive impact on the stock price.